Definitive Healthcare (DH) Stock Price, News & Analysis

Company Overview

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.

Key Stats

• Today's Range: $2.60 to $2.74
• 50-Day Range: $2.45 to $5.55
• 52-Week Range: $2.15 to $7.47
• Volume: 487,675 shs
• Average Volume: 852,794 shs
• Market Capitalization: $294.70 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $5.35
• Consensus Rating: Hold

Definitive Healthcare Stock Analysis - MarketRank™

Definitive Healthcare scored higher than 34% of companies evaluated by MarketBeat, and ranked 488th out of 654 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Hold

Consensus Rating

Definitive Healthcare has received a consensus rating of Hold. The company's average rating score is 2.08, and is based on 3 buy ratings, 7 hold ratings, and 2 sell ratings.

Amount of Analyst Coverage

Definitive Healthcare has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: -12.50%

Earnings Growth

Earnings for Definitive Healthcare are expected to decrease by -12.50% in the coming year, from $0.16 to $0.14 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Definitive Healthcare is -0.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Definitive Healthcare is -0.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Definitive Healthcare has a PEG Ratio of 4.06. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Definitive Healthcare has a P/B Ratio of 0.25. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

9.05% of the float of Definitive Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Definitive Healthcare has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Definitive Healthcare has recently increased by 23.26%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Definitive Healthcare does not currently pay a dividend.

Dividend Growth

Definitive Healthcare does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

9.05% of the float of Definitive Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Definitive Healthcare has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Definitive Healthcare has recently increased by 23.26%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 1.4 / 5
• News Sentiment: 0.47

News Sentiment

Definitive Healthcare has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Computer and Technology companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Definitive Healthcare this week, compared to 3 articles on an average week.

MarketBeat Follows

Only 1 people have added Definitive Healthcare to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Definitive Healthcare insiders have not sold or bought any company stock.

Percentage Held by Insiders

14.84% of the stock of Definitive Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

98.67% of the stock of Definitive Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

DH Stock Analysis - Frequently Asked Questions

How have DH shares performed this year?

Definitive Healthcare's stock was trading at $4.11 at the beginning of 2025. Since then, DH stock has decreased by 36.5% and is now trading at $2.61.
View the best growth stocks for 2025 here.

How were Definitive Healthcare's earnings last quarter?

Definitive Healthcare Corp. (NASDAQ:DH) announced its quarterly earnings results on Thursday, February, 27th. The company reported $0.03 earnings per share for the quarter, missing analysts' consensus estimates of $0.07 by $0.04. The firm earned $62.29 million during the quarter, compared to analyst estimates of $60.60 million. Definitive Healthcare had a positive trailing twelve-month return on equity of 1.76% and a negative net margin of 142.38%.
Read the conference call transcript.

When did Definitive Healthcare IPO?

Definitive Healthcare (DH) raised $350 million in an initial public offering (IPO) on Wednesday, September 15th 2021. The company issued 15,555,555 shares at a price of $21.00-$24.00 per share.

Who are Definitive Healthcare's major shareholders?

Top institutional investors of Definitive Healthcare include Rhumbline Advisers (0.07%), Baker Tilly Wealth Management LLC (0.05%) and Hennion & Walsh Asset Management Inc. (0.04%). Insiders that own company stock include Sea Vii Management, Llc, William Moschella and Jeffrey Charles Haywood.
View institutional ownership trends.

How do I buy shares of Definitive Healthcare?

Shares of DH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Definitive Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Definitive Healthcare investors own include AUO (AUOTY), American Water Works (AWK), Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), Triple Flag Precious Metals (TFPM) and iShares Micro-Cap ETF (IWC).

Company Calendar

• Last Earnings: 2/27/2025
• Today: 4/23/2025
• Next Earnings (Estimated): 5/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: Prepackaged software
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:DH
• CIK: 1861795
• Web: www.definitivehc.com
• Phone: 508-720-4224
• Fax: N/A
• Employees: 970
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $5.35
• High Stock Price Target: $8.00
• Low Stock Price Target: $3.00
• Potential Upside/Downside: +104.6%
• Consensus Rating: Hold
• Rating Score (0-4): 2.08
• Research Coverage: 12 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($3.52)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 16.34
• P/E Growth: 4.06
• Net Income: $-202,390,000.00
• Net Margins: -142.38%
• Pretax Margin: -217.05%
• Return on Equity: 1.76%
• Return on Assets: 1.12%

Debt

• Debt-to-Equity Ratio: 0.33
• Current Ratio: 2.49
• Quick Ratio: 2.49

Sales & Book Value

• Annual Sales: $252.20 million
• Price / Sales: 1.17
• Cash Flow: $1.57 per share
• Price / Cash Flow: 1.67
• Book Value: $10.31 per share
• Price / Book: 0.25

Miscellaneous

• Outstanding Shares: 112,911,000
• Free Float: 98,379,000
• Market Cap: $295.26 million
• Optionable: Not Optionable
• Beta: 1.48